LncRNA POU3F3 Contributes to Dacarbazine Resistance of Human Melanoma Through the MiR-650/MGMT Axis.

Wu, Kai; Wang, Qiang; Liu, Yu-Lin; Xiang, Zhuo; Wang, Qing-Qing; Yin, Li; Liu, Shun-Li

Wu, Kai; Wang, Qiang; Liu, Yu-Lin; Xiang, Zhuo; Wang, Qing-Qing; Yin, Li; Liu, Shun-Li.

Afiliação

Wu K; Department of Burns and Plastic Surgery, People's Liberation Army (PLA) 960 Hospital, Jinan, China.
Wang Q; Oncology Department, Shandong Second Provincial General Hospital, Jinan, China.
Liu YL; Clinical Laboratory, Navy 971 Hospital of PLA, Qingdao, China.
Xiang Z; Clinical Laboratory, Navy 971 Hospital of PLA, Qingdao, China.
Wang QQ; Pharmacy Department, Navy 971 Hospital of PLA, Qingdao, China.
Yin L; Oncology Department, Shandong Second Provincial General Hospital, Jinan, China.
Liu SL; Oncology Department, Shandong Second Provincial General Hospital, Jinan, China.

Front Oncol ; 11: 643613, 2021.

Article em En | MEDLINE | ID: mdl-33816296

Palavras-chave

MGMT; chemo-resistance; dacarbazine; lncRNA POU3F3; melanoma

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Front Oncol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google